As I write this, doctors are attempting once again to take him out of the coma they induced to stem the swelling of his brain. Though he still has a long way to go, I'm happy to say he has made great strides in the past 10 days.

In another case, doctors in Indiana recently used an experimental drug to treat a 30-year-old mother who has made an amazing recovery from her brain injury.

It's based on the female hormone progesterone. You see, doctors already knew that young women recover from brain trauma faster than men.

Studies with pregnant rats also showed they recovered more quickly than non-pregnant rats. And male rats that got progesterone also fared better.

Now, a team led by Emory University in Atlanta is in Phase III of a key clinical trial. It covers more than 1,000 patients at 17 U.S. medical centers.

The fact that the study already cleared major hurdles bodes well for its outcome. If the test succeeds it could mean that a new drug to treat brain injuries will hit the market in just a few years.

Stem Cells Open Paths to New Cures

Our brains are teeming with nerve cells called neurons. To work correctly, neurons rely on very special nerve fibers called axons.

Simply put, when axons are too damaged from trauma the patient dies. That's why the Texas team's work is so important.

Team members implanted neural stem cells into rat brains and made two major findings. The stem cells not only reduced brain damage, they also lowered levels of a deadly protein that courses through the brain after it suffers an impact.

Stem cells hold great promise for the long haul because they are natural. That means no drug side effects and the chance to have healthy cells grow new tissue.

It's why I believe it's just a matter of time before a biotech firm comes to market with an effective drug or treatment for brain injuries. Success here could be huge.

At the very least it will save us billions a year in healthcare costs alone.

As investors, that lets us make money while also saving lives.

In fact, I believe that in as little as a decade I will be able to report to you that thousands of patients like Matt have bounced back from their brain injuries.

It is one of the reasons I am so hopeful for America's future. Breakthroughs like these are part of our DNA.

It's why I just launched the Era of Radical Change to keep you abreast of this and other cutting-edge technology.

It is a unique advisory service that will show you how to profit from the most important trends reshaping the world around us.

I'm referring to things like:

Crab-like robots that eat cancer.

Nanosatellites that can fly to the moon on a single drop of fuel.

Gold nanoparticles that can help get rid of brain tumors.

And much, much more…

So, if you want to find a way to profit from the next generation of tech breakthroughs, please join me at the Era of Radical Change.

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top technology financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.

He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.

As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

Michael is 100% independent and receives absolutely no compensation from companies he writes about. His ideas are completely his own.

So, it probably goes without saying that you won't ever be left in the dark about breaking innovations, ahead-of-their-time technologies, and breakout companies on the cusp of changing the world once you join this world.

6

Leave a Reply

I would like to invest but I don't have a lot of money could you let me know how to go about it thank you

Vote Up0Vote Down Reply

May 3, 2012 8:46 am

Guest

Robert Streetman

How are you? I have been brain injury survivor for 23 years now. I got shot by my ex-girlfriend. And it has been struggle. But when I think about my injury and thank God that I am still here. I am a Rotary Club member and Big Brothers Big Sisters member. Thank you.

Vote Up0Vote Down Reply

May 3, 2012 9:16 am

Guest

Publius

What the article fails to mention is that the breakthroughs have occurred with ADULT stem cells, not embryonic stem cells. This has been true for every single scientific use of stem cells.

Vote Up0Vote Down Reply

May 3, 2012 9:23 am

Guest

Pieter

Thank you for pointing that out Publius. The ethics underlying these advances is really even more important than the promising positive outcome of this research.

Vote Up0Vote Down Reply

May 3, 2012 9:23 pm

Guest

Diana Hoeflein

RE: Recovering from my Brain Injury INTRACEREBRAL HEMORRHAGE: FEB 2, 2012 I receive almost daily my Money Morning email and the May 3rd issue was caught me offguard talking about brain injuries bacause I too just went through one February 2, 2012. I was falling off ladders for unexplained reasons when I started fixing painting problems that my December 2011 painting people made in 2 bathrooms where they let the wall paint blend into the ceiling so while up there and also cleaning outside windows, I fell several times and hit my head, I know on the tub in the… Read more »

Vote Up0Vote Down Reply

May 4, 2012 10:44 am

Guest

Paolo

I wonder if rehabilitation clinics will survive. I believe that stem cell cures cannot go alone without proper rehabilitation and rehabilitation devices like existing devices that let patients walk (sort of) while they are still in a coma.

Vote Up0Vote Down Reply

May 7, 2012 11:12 am

Profit Alerts

Never miss a profit pick again.

Choose from the topics below to receive our money-making recommendations in real time.

By submitting your email address you will receive a free subscription to Money Morning and receive Money Morning Profit Alerts. You will also receive occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

Our Top Rated Stocks

You can view our VQScore top-rated stocks now by entering your email below:

By submitting your email address you will receive a free subscription to VQScore and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

Today's Markets

DJIA829.16(3.15%)27,110.98

NASDAQ198.27(2.06%)9,814.08

S&P81.58(2.62%)3,193.93

ABOUT MONEY MORNING

Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

By submitting your email address you will receive a free subscription to Money Morning and receive Money Morning Profit Alerts. You will also receive occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.